Literature DB >> 30221902

[HIV-1 integrase inhibitor resistance among treatment naïve patients in Gran Canaria, 2017].

M J Pena López1, M Hernández Febles, J A Medina Galindo, R D Pérez Jiménez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30221902      PMCID： PMC6194871     

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN： 0214-3429            Impact factor:   1.553


× No keyword cloud information.
  10 in total

1.  Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan.

Authors:  Chung-Chih Lai; Wen-Chun Liu; Chi-Tai Fang; Jyh-Yuan Yang; Lan-Hsin Chang; Pei-Ying Wu; Yu-Zhen Luo; Shu-Fang Chang; Yi-Ching Su; Sui-Yuan Chang; Chien-Ching Hung
Journal:  J Antimicrob Chemother       Date:  2015-09-23       Impact factor: 5.790

2.  Primary resistance to integrase strand-transfer inhibitors in Europe.

Authors:  M Casadellà; P M van Ham; M Noguera-Julian; A van Kessel; C Pou; L M Hofstra; J R Santos; F Garcia; D Struck; I Alexiev; A M Bakken Kran; A I Hoepelman; L G Kostrikis; S Somogyi; K Liitsola; M Linka; C Nielsen; D Otelea; D Paraskevis; M Poljak; E Puchhammer-Stöckl; D Staneková; M Stanojevic; K Van Laethem; S Zidovec Lepej; B Clotet; C A B Boucher; R Paredes; A M J Wensing
Journal:  J Antimicrob Chemother       Date:  2015-07-17       Impact factor: 5.790

3.  Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.

Authors:  Alexandra U Scherrer; Wan-Lin Yang; Roger D Kouyos; Jürg Böni; Sabine Yerly; Thomas Klimkait; Vincent Aubert; Matthias Cavassini; Manuel Battegay; Christoph Hauser; Alexandra Calmy; Patrick Schmid; Enos Bernasconi; Huldrych F Günthard
Journal:  J Infect Dis       Date:  2016-04-29       Impact factor: 5.226

4.  Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.

Authors:  Sarita D Boyd; Frank Maldarelli; Irini Sereti; G Laissa Ouedraogo; Catherine A Rehm; Valerie Boltz; Diana Shoemaker; Alice K Pau
Journal:  Antivir Ther       Date:  2011

5.  Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy.

Authors:  Benjamin Young; Signe Fransen; Kenneth S Greenberg; Amy Thomas; Sharon Martens; Marty St Clair; Christos J Petropoulos; Belinda Ha
Journal:  Antivir Ther       Date:  2011

6.  Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017).

Authors: 
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2017-06-01

7.  HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland.

Authors:  A Bradley-Stewart; C Urcia; A MacLean; C Aitken; R Gunson
Journal:  J Clin Virol       Date:  2017-04-23       Impact factor: 3.168

8.  Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.

Authors:  Slim Fourati; Charlotte Charpentier; Corinne Amiel; Laurence Morand-Joubert; Sandrine Reigadas; Mary-Anne Trabaud; Constance Delaugerre; Florence Nicot; Audrey Rodallec; Anne Maillard; Audrey Mirand; Hélène Jeulin; Brigitte Montès; Francis Barin; Dominique Bettinger; Hélène Le Guillou-Guillemette; Sophie Vallet; Anne Signori-Schmuck; Diane Descamps; Vincent Calvez; Philippe Flandre; Anne-Genevieve Marcelin
Journal:  J Antimicrob Chemother       Date:  2015-01-03       Impact factor: 5.790

9.  Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials.

Authors:  Jiangzhou You; Hongren Wang; Xiaojun Huang; Zhen Qin; Zhaomin Deng; Jun Luo; Baoning Wang; Mingyuan Li
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

10.  Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades.

Authors:  Tomas Doyle; David T Dunn; Francesca Ceccherini-Silberstein; Carmen De Mendoza; Frederico Garcia; Erasmus Smit; Esther Fearnhill; Anne-Genevieve Marcelin; Javier Martinez-Picado; Rolf Kaiser; Anna Maria Geretti
Journal:  J Antimicrob Chemother       Date:  2015-08-26       Impact factor: 5.790
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.